Redeye: Bredband2 - Future margin improvements
Redeye makes minor forecast adjustments following Bredband2’s Q1 2023 report, in which sales came in slightly below our expectations, while the margins were somewhat above due to lower OPEX than anticipated. Accordingly, we update our forecast marginally while our fair value range is intact.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/